Texas 2025 - 89th Regular

Texas House Bill HB4638 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	89R9891 MPF-D
2	2	By: Bonnen H.B. No. 4638
3	3
4	4
5	5
6	6
7	7	A BILL TO BE ENTITLED
8	8	AN ACT
9	9	relating to the Texas Pharmaceutical Initiative.
10	10	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
11	11	SECTION 1. Section 2177.003(a), Government Code, is amended
12	12	to read as follows:
13	13	(a) The initiative is governed by a board composed of five
14	14	[three] members appointed by the governor.
15	15	SECTION 2. Chapter 2177, Government Code, is amended by
16	16	adding Section 2177.0035 to read as follows:
17	17	Sec. 2177.0035. TERMS; VACANCIES. (a) Board members serve
18	18	staggered six-year terms, with one-third or as near as possible to
19	19	one-third of the members' terms expiring February 1 of each
20	20	odd-numbered year.
21	21	(b) A vacancy on the board shall be filled for the unexpired
22	22	term in the same manner as the original appointment.
23	23	SECTION 3. Section 2177.006, Government Code, is amended to
24	24	read as follows:
25	25	Sec. 2177.006. BUSINESS PLAN. Not later than June 1 of each
26	26	even-numbered year [October 1, 2024], the board shall prepare
27	27	[develop] and submit to the governor, the legislature, and the
28	28	Legislative Budget Board a business plan on:
29	29	(1) implementing the initiative, including the
30	30	initiative's organizational structure and related programs;
31	31	(2) establishing procedures and policies for the
32	32	administration of the initiative, including documenting the
33	33	process and resources required for the provision to individuals
34	34	described by Section 2177.002 of the following services:
35	35	(A) establishing or contracting for statewide
36	36	pharmacy benefit manager services;
37	37	(B) establishing policies and conditions to
38	38	operate or contract for the operation of a distribution network,
39	39	central service center, and associated network of satellite
40	40	distribution facilities to distribute prescription drugs and
41	41	related medical supplies; and
42	42	(C) providing advanced pharmaceutical
43	43	preparation and related services, including:
44	44	(i) manufacturing generic drugs and generic
45	45	biological products;
46	46	(ii) providing gene therapies and precision
47	47	medicine; and
48	48	(iii) providing advanced laboratories for
49	49	quality control, preparation, and compounding of drugs in support
50	50	of innovative therapeutics and drug research;
51	51	(3) establishing procedures to document compliance by
52	52	board members and personnel with applicable laws governing
53	53	conflicts of interest;
54	54	(4) establishing the conditions for state agencies
55	55	that facilitate health plans to participate in the initiative;
56	56	(5) identifying potential cost savings from
57	57	implementation of the initiative;
58	58	(6) identifying the funding and resources needed to
59	59	implement this chapter; and
60	60	(7) providing other board recommendations, with
61	61	supporting documentation, on continuation of the initiative.
62	62	SECTION 4. Section 2177.010, Government Code, is repealed.
63	63	SECTION 5. (a) As soon as practicable after the effective
64	64	date of this Act, the governor shall appoint the governing board
65	65	members for the Texas Pharmaceutical Initiative as required by
66	66	Section 2177.003, Government Code, as amended by this Act.
67	67	(b) Notwithstanding Section 2177.0035, Government Code, as
68	68	added by this Act, in making the appointments of the governing board
69	69	members for the Texas Pharmaceutical Initiative under Subsection
70	70	(a) of this section, the governor shall designate:
71	71	(1) two members to serve terms expiring February 1,
72	72	2027;
73	73	(2) two members to serve terms expiring February 1,
74	74	2029; and
75	75	(3) one member to serve a term expiring February 1,
76	76	2031.
77	77	SECTION 6. This Act takes effect September 1, 2025.